person

Tilman P.

Country
Germany
Department
Department for Epilepsy

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
9
Sites with multiple studies

Has run more than one trial at 9 of 45 partner sites.

Specializations

Rare Epileptic Conditions

This investigator specializes in treating severe and rare epileptic disorders, with particular focus on Myoclonic Astatic Epilepsy (Doose Syndrome). Their research extends to managing complex seizure patterns in pediatric populations.

  • Doose Syndrome Management
  • Long-term Seizure Control
  • Add-on Therapeutic Approaches

The investigator's work emphasizes innovative therapeutic strategies for treatment-resistant epilepsy cases.

Early-Onset Epilepsy

Focusing on Dravet syndrome in infants, the investigator studies therapeutic interventions for early-life epileptic conditions. Their expertise includes evaluating treatment responses in very young patients between ages 1-2 years.

  • Infant Epilepsy Treatment
  • Safety Monitoring in Young Patients
  • Pharmacological Response Assessment

Special attention is given to developing safe and effective treatment protocols for infant populations.

Genetic Disorders

The investigator conducts research in CDKL5 Deficiency Disorder, exploring treatment options for this rare genetic condition. Their work encompasses both pediatric and adult patients affected by this disorder.

  • Genetic Epilepsy Treatment
  • Long-term Clinical Management
  • Multi-age Treatment Strategies

Research focuses on developing comprehensive treatment approaches for genetic epileptic disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.